COMMUNIQUÉS West-GlobeNewswire

Marrone Bio Innovations to Attend Upcoming Investor Conferences in May
01/05/2019
DAVIS, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ:MBII) (MBI), a leading developer of biological crop protection and plant health solutions, today announced that management will attend [...]
Yield10 Bioscience to Announce First Quarter 2019 Financial Results and Host a Conference Call on Thursday, May 9, 2019
01/05/2019
WOBURN, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ: YTEN), an agricultural bioscience company which uses its “Trait Factory” to develop high value seed traits for the agriculture and food [...]
Eyenovia Announces Conference Call and Webcast for First Quarter 2019 Financial Results
01/05/2019
NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN), a clinical stage ophthalmic biopharmaceutical company developing a pipeline of microdose therapeutics utilizing its patented piezo-print delivery [...]
Allogene Therapeutics Announces Expansion of Scientific Advisory Board
01/05/2019
Newly Appointed Members Include Robert Abraham, Ph.D., Malcolm K. Brenner, M.D., Ph.D., Stephen J. Forman, M.D., and Wendell Lim, Ph.D. SOUTH SAN FRANCISCO, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics [...]
L-DOS47 Phase II Randomized Study Advances to Second Cohort
01/05/2019
RICHMOND HILL, Ontario, May 01, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of [...]
Zogenix to Release First Quarter 2019 Financial Results and Host Conference Call and Webcast on May 8
01/05/2019
EMERYVILLE, Calif., May 01, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the [...]
Tyme Technologies to Participate at the SunTrust Robinson Humphrey 5th Annual Life Sciences Summit on May 7th
01/05/2019
NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME) , an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that management will present at the [...]
Jounce Therapeutics to Announce First Quarter 2019 Financial Results and Host Conference Call on Wednesday, May 8, 2019
01/05/2019
CAMBRIDGE, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Todos Medical Receives Notice of Allowance from the USPTO Covering the Early Diagnosis of Lung Cancer Using the Todos Biochemical Infrared Analysis (TBIA)
01/05/2019
REHOVOT, Israel and NEW YORK, May 01, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer [...]
Abeona Therapeutics Reports Preclinical Data Demonstrating Broad Therapeutic Potential of AIM™ Gene Therapy in Retinal Diseases at Association for Research in Vision and Ophthalmology Annual Meeting
01/05/2019
NEW YORK and CLEVELAND, May 01, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that intravitreal administration of the Company’s [...]
VBI Vaccines Announces First Quarter 2019 Financial Results and Provides Corporate Update
01/05/2019
All four lead pipeline programs progressing towards expected clinical milestones in 2019 Gearing up for top-line data from the pivotal Phase 3 study of Sci-B-Vac®, VBI’s trivalent hepatitis B vaccine, expected mid-year [...]
Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/05/2019
CAMBRIDGE, Mass., May 01, 2019 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in [...]
IntelGenx Announces Issuance of Second U.S. Patent for Topical Oral Film Technology
01/05/2019
SAINT LAURENT, Quebec, May 01, 2019 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) (“IntelGenx”), a leading oral drug delivery company, today announced that the United States Patent and Trademark Office [...]
Phoenix Life Announces $40 Million Capital Raise in Conjunction with TABOR Family Office Conference
01/05/2019
DENVER, CO, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE - Phoenix Life Sciences International Limited (OTC: PLSI) (“Phoenix Life” or the “Company”), an adaptive healthcare solutions company, today announced that [...]
Tauriga Sciences, Inc. Enters into Distribution Agreement Focused on Tauri-Gum Sales Throughout Northeast Region of USA and Asia
01/05/2019
NEW YORK, NY, May 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Tauriga Sciences, Inc. (OTCQB: TAUG ) (“Tauriga” or the “Company”), a revenue generating Company that operates through the development, distribution, and [...]
Adaptimmune to Provide Clinical and Business Update on Monday May 6th, 2019
01/05/2019
PHILADELPHIA and OXFORDSHIRE, United Kingdom, May 01, 2019 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, will provide a clinical and business update before [...]
Xeris Pharmaceuticals Announces Results From a Phase 1 Study of Its Novel Formulation of Diazepam
01/05/2019
Favorable pharmacokinetic, safety, and tolerability results support continued development of Xeris’ diazepam Phase 2 study to be initiated in 2H2019 CHICAGO, May 01, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc [...]
Stryker declares a $0.52 per share quarterly dividend
01/05/2019
Kalamazoo, Michigan, May 01, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.52 per share payable on July 31, 2019 to shareholders of record at [...]
Abeona Therapeutics présente des données précliniques démontrant un large potentiel thérapeutique de la thérapie génique AIM™ dans les maladies rétiniennes lors de l'assemblée générale annuelle de l'Association for Research in Vision and Ophthalmology
01/05/2019
NEW YORK et CLEVELAND, 01 mai 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), chef de file totalement intégré dans la thérapie génique et cellulaire, a annoncé aujourd'hui que l'administration [...]

Pages